Alphatec Holdings, Inc. ATEC
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus
Chart by TradingView
6/9
Piotroski F — financial health
-4.63
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $764.2M | -$143.4M | $531.9M | $2.8M | $12.4M |
| 2024 | $611.6M | -$162.1M | $424.3M | -$127.9M | -$14.2M |
| 2023 | $482.3M | -$186.6M | $310.2M | -$159.0M | $78.1M |
| 2022 | $350.9M | -$151.3M | $233.1M | -$124.6M | -$34.7M |
| 2021 | $243.2M | -$143.0M | $157.8M | -$141.9M | $80.7M |
| 2020 | $144.9M | -$79.0M | $102.5M | -$69.5M | $129.9M |
Why these scores methodology →
Piotroski F-score: 6/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -4.63 (distress)
- Working capital / assets 0.293
- Retained earnings / assets -1.8
- EBIT / assets -0.104
- Equity / liabilities 0.016
Source: SEC EDGAR filings · CIK 0001350653 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.